SUNRISE, Fla., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Transpire Bio, an integrated clinical-stage biopharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, ...
Federal antitrust officials have redoubled efforts to challenge what they see as improper pharma patent listings that delay the market entry of generic drugs. This week, the Federal Trade Commission ...
Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) is a prescription inhaler used to treat asthma or COPD in adults. This drug can interact with certain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results